A study shows epigenetic proteins regulate genes through diverse dynamic patterns, not simple on-off control, with each ...
Many new gene therapy treatments aren’t as profitable as predicted. But the reasons why don’t quite fit Goldman Sachs’ ...
Q1 2026 Earnings Call April 21, 2026 8:00 AM EDTCompany ParticipantsRachel VatnsdalRainer Blair - President, CEO ...
The vision of a single blood test that could screen for dozens of different cancers has tantalized oncologists for more than ...
This study characterizes several novel activities of SARS-CoV-2 helicase nsp13, providing valuable insights into potentially new functions of this essential RNA-processing enzyme in the virus life ...
NCBioImpact, a public/private partnership created to bring together key resources to produce world-class biopharma ...
No. 7 / 2026Zealand Pharma launches long-term incentive programs for Zealand Pharma’s Board of Directors, Corporate ...
TONMYA (cyclobenzaprine HCl sublingual tablets) for long-term daily dosing at bedtime, is the first new FDA-approved ...
DSS, Inc. (NYSE American: DSS) today issued the following letter to shareholders from the Interim CEO, Jason Grady, highlightin ...
When the Trump administration announced its Most Favored Nation policy, it was portrayed as a simple, sensible idea. Drug ...
Future technology trends are reshaping daily life through AI, quantum sensors, brain interfaces, and biofabrication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results